ACE-031

Price range: $44.99 through $400.00

Wishlist Compare

Batch Number: 2606080470

Purity Percentage: 99.9

Identity Confirmation: ACE031 1mg Purity: 99.09% Identity: Confirmed Net Content: 1.28 mg Appearance: White Lyophilized Powder

Testing Methods: Method: HPLC with UV detection coupled with mass spectrometry (LC-MS). Method: Endotoxin testing performed using Limulus Amebocyte Lysate assay in accordance with USP under validated laboratory conditions. ACE-031 1 mg lot tested at 99.09% purity, identity was confirmed by LC-MS, measured net content was 1.28 mg, and both endotoxin replicates passed at ≤0.05 EU/mL

Credential Line: Freedom Diagnostics: OPTM2606080470

Test Date: 09/06/2026

View Lab Result

SKU: N/A Category:
Extra Features
  • Premium Quality
  • Secure Payments
  • Satisfaction Guarantee
  • Worldwide Shipping
  • Money Back Guarantee

Research Use Only

All research peptides supplied by OPTMZ Peptides are intended strictly for laboratory research applications and are not designed for medical use. These materials are not approved by the U.S. Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease. By purchasing, the buyer confirms use strictly for scientific research purposes and not for human or animal consumption.

Product Overview

ACE-031 is a recombinant research protein engineered from the extracellular ligand-binding domain of activin receptor type IIB (ActRIIB) fused to an immunoglobulin Fc domain. It has been investigated experimentally for its interaction with members of the transforming growth factor-beta (TGF-β) superfamily, including myostatin and related ligands involved in cellular growth and differentiation signaling.

ACE-031 functions experimentally as a soluble ligand-binding protein, making it useful in controlled laboratory studies examining ActRIIB-associated signaling, myostatin biology, skeletal-muscle signaling pathways, and TGF-β superfamily interactions

Technical Specifications

  • Product: ACE-031
  • Quantity: 1 mg
  • Research Classification: ActRIIB-Fc fusion protein
  • Target Pathway: Activin receptor type IIB (ActRIIB) ligand signaling
  • Purity: 99.09% (HPLC-UV tested, current lot)
  • Identity: Confirmed by LC-MS
  • Form: White lyophilized powder
  • Measured Net Content: 1.28 mg
  • Lot: ACE1

Analytical & Testing

Each tested batch of ACE-031 undergoes analytical evaluation to verify identity, purity, and analytical consistency. A corresponding Certificate of Analysis (COA) is available for the tested lot.

For the current OPTMZ Peptides lot, independent testing reported:

  • Identity (LC-MS): ACE-031 — Confirmed
  • Purity (HPLC-UV): 99.09%
  • Measured Net Content: 1.28 mg
  • Appearance: White lyophilized powder
  • Endotoxin Replicate 1: Pass
  • Endotoxin Replicate 2: Pass
  • Assay Sensitivity: ≤0.05 EU/mL
  • Lot: ACE1

The laboratory reports HPLC with UV detection coupled with mass spectrometry (LC-MS), while endotoxin testing was performed using a Limulus Amebocyte Lysate assay in accordance with USP <85> under validated laboratory conditions.

Handling & Storage

ACE-031 should be handled by qualified professionals in controlled laboratory environments. Appropriate storage conditions should be maintained to preserve protein stability and structural integrity.

Avoid unnecessary exposure to heat, moisture, and repeated temperature fluctuations. Experimental preparation and handling procedures should follow validated laboratory protocols appropriate to the research application.

Research Context

ACE-031 has been investigated in controlled experimental systems involving TGF-β superfamily signaling and ActRIIB-associated pathways. Research areas include:

  • Activin receptor type IIB pathway research
  • Myostatin-associated signaling
  • TGF-β superfamily ligand interactions
  • Skeletal-muscle biology
  • Cellular growth and differentiation pathways
  • Ligand-receptor binding models
  • Protein signaling mechanisms
  • ActRIIB pathway modulation

These observations relate to experimental research and do not establish therapeutic efficacy or safety for human use.

Research Application Scope

ACE-031 continues to be relevant to experimental biology involving ActRIIB ligand interactions and TGF-β superfamily signaling.

Its engineered soluble receptor structure allows researchers to investigate ligand sequestration and downstream signaling associated with myostatin, activins, and related signaling proteins in controlled experimental models.

Use Statement

For laboratory research use only. Intended strictly for in vitro research applications.

Disclaimer

All products currently listed on this site are for research purposes ONLY.

Pcs

Single Vial, Pack Of 10

Reviews

There are no reviews yet.

Be the first to review “ACE-031”

Your email address will not be published. Required fields are marked *